FLUDEOXYGLUCOSE F18
Generic: FLUDEOXYGLUCOSE F18
MIPS Cyclotron & Radiochemistry FacilityManufacturer
INTRAVENOUSRoute
FLUDEOXYGLUCOSE F-18Active Substance
2015-09-11Original Approval
FLUDEOXYGLUCOSE F18 is FDA application ANDA204472, sponsored by MIPS CRF. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
CYTOKINE RELEASE SYNDROME
23 reports
2
DRUG INEFFECTIVE
16 reports
3
NAUSEA
16 reports
4
OFF LABEL USE
15 reports
5
NEUTROPENIA
13 reports
6
PYREXIA
12 reports
7
HYPOTENSION
11 reports
8
PLATELET COUNT DECREASED
11 reports
9
RASH MACULO-PAPULAR
11 reports
10
BONE MARROW FAILURE
10 reports